Dr Emmanuel Ferrer

MD (Internal Medicine)

Principal Investigator – Nucleus Network, Minneapolis

Dr. Emmanuel Ferrer has over 20 years of clinical experience and joined Nucleus Network in 2021 as Principal Investigator. He has supervised first-in-human clinical trials and studies involving novel first-in-class pharmacological therapeutics. His experience at Nucleus Network, combined with his clinical acumen, has honed his expertise in ensuring the safe participation of normal-healthy and hepatically-impaired research volunteers.

During his tenure at the Centers for Disease Control as a Regional Medical Officer during the COVID-19 pandemic, Dr. Ferrer implemented the methodical observance of preventive medical measures. This experience paved the way for his leadership over Phase 1 through Phase 3 vaccine clinical trials at Nucleus Network, including the responsible administration of developmental vaccines for Pneumonia and Influenza.

Having worked at the Weight Management Center at the Mayo Clinic, he has developed a keen interest on investigational medications for the treatment of obesity and has aligned with the Obesity Trial Network Initiative.

Driven by a dedication to medical innovation, Dr. Ferrer continues to lead research that bridges scientific discovery with real-world patient and community care.